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Neuroexocytosisa b s t r a c t
Synaptotagmin is a synaptic vesicle membrane protein which changes conformation upon Ca2+
binding and triggers the fast neuroexocytosis that takes place at synapses. We have synthesized a
series of peptides corresponding to the sequence of the cytosolic juxtamembrane domain of synap-
totagmin, which is highly conserved among different isoforms and animal species, with or without
either a hexyl hydrophobic chain or the hexyl group plus a ﬂuorescein moiety. We show that these
peptides inhibit neurotransmitter release, that they localize on the presynaptic membrane of the
motor axon terminal at the neuromuscular junction and that they bind monophosphoinositides
in a Ca2+-independent manner. Based on these ﬁndings, we propose that the juxtamembrane cytoso-
lic domain of synaptotagmin binds the cytosolic layer of the presynaptic membrane at rest. This
binding brings synaptic vesicles and plasma membrane in a very close apposition, favouring the
formation of hemifusion intermediates that enable rapid vesicle fusion.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Neuroexocytosis is a central function of physiology and behav-
ior and it consists of the Ca2+-regulated fusion of cytosolic neuro-
transmitter/neuropeptide containing vesicles (SV) with the
presynaptic membrane (PM) with release of its content into the
synaptic cleft. Neuroexocytosis is mediated by a nanomachine that
includes components located on the SV membrane, in the cytosol
and on the PM cytosolic face [1–3]. SNAP-25 and syntaxin project
their protein mass into the cytosol and can form a coiled–coil
complex with a SV protein termed VAMP/synaptobrevin. This
heterotrimeric oligomer is termed SNARE complex [4] and the
determination of its structure has indicated that SNARE complex
formation occurs via coil-coiling of a 60 residues long SNAREdomain present in the sequence of VAMP, SNAP-25 and syntaxin
[5]. Other proteins play a major role in SV docking to the PM, but
the SNARE complex and the SV Ca2+ binding protein synaptotag-
min are those involved in the membrane fusion process which ulti-
mately leads to the release of the SV content [6].
There is evidence that three or more SNARE complexes are
required for neuroexocytosis to occur, i.e. a supercomplex of
SNARE complexes is required [7–14]. The number of SNARE com-
plexes present in such a nanomachine has not yet been determined
with certainty and different events of exocytosis may require
SNARE supercomplexes of different stoichiometries. Two cytosolic
proteins, Munc-18 and complexin, are essential for the correct
assembly of the neuroexocytosis nanomachine by regulating
different stages of the formation of the SNARE complex and
supercomplex [6]. A tentative arrangement of the supercomplex
required for ultrafast neuroexocytosis has been proposed [3].
Synaptotagmins (Syt) form a large family of proteins which
basically include a intravesicular domain of varying size, a trans-
membrane domain (TM) and a linker segment that connects the
TM to two consecutive C2 domains that are exposed to the cytosol
[15–17] (Fig. 1). Syt binds Ca2+ via the C2 domains each of which
contains a conserved polycationic segment that binds anionic PM
phospholipids, including phosphatidylserine and phosphatidylino
Fig. 1. Juxtamembrane polybasic peptide in synaptotagmin sequences. (A)
Schematic representation of synaptotagmin domains. LD: lumenal domain; TM:
transmembrane domain; L: linker domain; C2A and B: calcium binding domains;
JMS: juxtamembrane Segment. The length of each box is proportional to the
number of AA in the real sequence. Red asterisks indicate clusters of positive
residues. (B) Sequence alignment of synaptotagmin-1 juxtamembrane segment in
different species, obtained from www.uniprot.org; yellow indicates transmem-
brane domain, green basic residues. (C–F) Peptides used in this study. (C) Peptide
corresponding to synaptotagmin polybasic segment (JMS, residues 80-98 in mouse
sequence); (D) Modiﬁed peptide, with the hexyl moiety (h-JMS); (E) Scrambled
peptide (h-sJMS); (F) Fluorescent peptide (h-FJMS).
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brane penetration and induction of a positive curvature in the
PM [18–25]. This interaction leads to membrane penetration of
segments of the C2 domain and to the bridging of the SV and PM
membranes [26,27]. There is a growing consensus on the possibil-
ity that Ca2+ and anionic phospholipid binding to synaptotagmin
triggers its rapid conformational change that is transmitted to
the SNARE supercomplex leading to SV-PM fusion with the deliv-
ery of the vesicle content to the post-synaptic cell [2,3,6,17,
18,21–23,28]. In the case of the neuromuscular junction synapse
(NMJ), which is studied here, the released neurotransmitter is
acetylcholine that migrates across the intersynaptic space to
induce the opening of the acetylcholine receptor channel [29–31].
Here, we have attempted to determine the possible role in neu-
roexocytosis of the highly cationic juxtamembrane segment of Syt
by testing the effect of corresponding peptides on neurotransmitter
release at the mouse and Drosophila melanogaster NMJ. Our
approach is based on the known property of highly cationic
peptides to cross the plasma membrane of cells [32–34]. We found
that these peptides induce a rapid neuroparalysis, bind phosphoinosi-
tides inaCa2+ independentmodeand largely localizeon thepresynap-
ticmembrane. Based on these ﬁndings, we propose a possible activity
of the juxtamembrane segment of Syt in neuroexocytosis.
2. Results
2.1. Juxtamembrane polybasic peptides of synaptotagmin are powerful
inhibitors of neuroexocytosis in the insect and mammalian synapses
Fig. 1 shows that the juxtamembrane segment of Syt 1 contains
a set of positively charged residues that has the potential to inter-
act with anionic phospholipids. This aminoacid sequence is highly
conserved among the Syts involved in neuroexocytosis and among
different species suggesting that it plays an important role inneuroexocytosis [16]. The NMJ also expresses Syt2 [35], but the
juxtamembrane segment of this Syt isoform contains three cys-
teine residues that generate all kind of artifacts owing to the pos-
sibility of generating intra and inter disulﬁde bonds.
The peptide corresponding to the juxtamembrane segment
(JMS) of the mouse neuronal Syt isoform 1 (segment 80–98 of
the mouse sequence) was synthesized with or without an hexyl
chain at its N-terminus to mimic the TM binding to the lipid bilayer
(lower part of Fig. 1), also on the basis of a previous study where
the TM domains of VAMP/synaptobrevin and of syntaxin where
replaced by hydrocarbon chains [36]. A peptide with a scrambled
distribution of the same residues along the sequence was also pre-
pared to be used as a control.
The effect of the peptides was ﬁrst tested in the mouse phrenic
hemidiaphragm nerve preparation, a well established model of ex
vivo neuromuscular junction (NMJ). Both the JMS peptide and its
hexyl derivative (h-JMS) are able to inhibit the nerve-stimulated
contraction of the muscle. The JMS peptide is a less effective inhi-
bitor of muscle twitching that its hexylated counterpart, as
expected on the basis of the higher membrane partition of the lat-
ter compound (Fig. 2A). We have used up to 0.2 mM concentration
only in the hemidiaphragm NMJ; this preparations is >99% muscle
volume and only a minor fraction is nerve terminals. In fact, the
end plate is less than 0.1% of the total muscle surface [37].
Accordingly, the predominant muscle will take up peptide and
therefore the effective amount of peptide available for the nerve
terminal is greatly reduced. At the end of each experiment the
integrity of the muscle was tested and the peptides were found
to have no effect on muscle contraction.
The hexyl scrambled peptide (h-sJMS) has a residual effect,
which can be attributed to the high number of cationic residues
that inevitably makes it partially similar to the native segment in
terms of charge distribution. This ﬁnding indicates that electro-
static interactions play an important, but not unique, role in the
inhibitory effect. However, at lower concentrations (below
100 lM), h-sJMS is without effect (black line in Fig. 2B), whereas
the native sequence still induces a deﬁned reduction of muscular
twitch. The scrambled peptide was designed by the software
‘PepControls’ (http://bioware.ucd.ie) and retains the same charge
as the sequence from the synaptotagmin one. It seems very
unlikely that the relative positions of the charged residue in the
sequence of h-JMS and h-sJMS would alter their permeability to
membranes. In fact the peptide chain and its lateral chains are ﬂex-
ible and the membrane permeating species is a complex among the
cationic peptide and the anionic plasma membrane lipid. Thus it is
safe to assume that the relative lack of effects of the control pep-
tide h-sJMS are not a consequence of it having an unexpected
low rate of entry into cells. Likewise, h-JMS and h-sJMS will have
the same general effect on membrane surface potential as the total
number of electric charges is the same.
In order to have a different read-out of the effect of the h-JMS
peptide on neuroexocytosis, another set of experiments was
performed using an intracellular electrode to record the evoked
junctional potentials (EJP) from the mouse diaphragm. Fig. 2C
shows that h-JMS inhibits very rapidly the EJPat the mouse NMJ.
As shown in Fig. 1, the juxtamembrane segment is conserved
among species and, therefore, we tested the effect of the h-JMS
on the D. melanogaster third instar larva NMJ. Fig. 2D shows that
this peptide is a highly effective inhibitor of neurotransmitter
(glutamate) release at the insect NMJ reinforcing the suggestion
that the JMS of Syt plays a major role in neuroexocytosis.
This process can be assayed directly by imaging the release of
appropriate ﬂuorescent dyes. Using rat primary spinal cord motor
neurons loaded with FM 1–43, we compared the release of the dye
in the presence or absence of the h-JMS peptide. As schematized in
Fig. 3A, for each experiment, regions corresponding to the synaptic
Fig. 2. Inhibition of the neuromuscular junction induced by synaptotagmin-derived peptides. (A and B) normalized muscular twitch of mouse hemidiaphragm preparations
after the addition, at time 0, of the indicated peptides. (A) Red trace: 200 lM hexyl-JMS (h-JMS), blue trace: 200 lM of the same peptide but without the hexyl hydrocarbon
chain (JMS); black trace: 200 lM hexyl-scrambled sequence (h-sJMS). (B) Black trace: 100 lM scrambled hexyl peptide (h-sJMS); purple trace: 50 lM h-JMS; orange trace:
100 lM h-JMS; red trace: 200 lM h-JMS as in A, for comparison. (C) Percentage reduction of EJPs, intracellularly recorded from single mouse diaphragm muscle ﬁbers, after
adding the speciﬁc peptide to the bath. Red trace: 100 lm h-JMS, black trace: 100 lM h-sJMS. (D) Percentage reduction of EJPs, intracellularly recorded from Drosophila
melanogaster 3rd instar larval muscles 6/7. The indicated peptides were added at time 0; red trace: 200 lm h-JMS, black trace: 200 lM h-sJMS.
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during the unloading phase; the slope that characterizes this
phenomenon (i.e., the speed of the exocytic event) was chosen to
compare different experiments. Using this experimental approach,
we observed a signiﬁcant inhibition of FM 1–43 release by the
h-JMS peptide, but not by the scrambled form (Fig 3B), further
supporting the indication that the juxtamembrane segment of
Syt is involved in neuroexocytosis.
2.2. The h-JMS peptide preferentially localizes at the presynaptic
membrane
To visualize the site(s) of binding and action of the h-JMS pep-
tide, we prepared a ﬂuorescent derivative (Fig. 1F, h-FJMS), using
an additional lysine residue to covalently bind the peptide both
to the hexyl moiety and to a ﬂuorescent moiety. This peptide
was tested in the hemidiaphragm preparation and found to inhibit
neurotransmitter release (not shown).
Fig. 4 shows that, in themouse hemidiaphragmNMJ preparation,
theh-FJMS staining is largely conﬁned to the presynapticmembrane
and the periplasmic area as indicated by the substantial overlap
with the staining of the presynaptic membrane marker Bassoon
and by its distribution with respect to the post-synaptic marker
a-bungarotoxin. This is particularly evident in the lateral section
(Fig. 5). Out of line with these results, unexpectedly, there is a com-
paratively lower stainingby theh-FJMSpeptide of the SVs,whichare
largely localized inside the motor axon terminal, as documented by
comparison with the staining of an antibody speciﬁc for the vesicu-
lar acetylcholine transporter (Fig. 6). Taken together these data
suggest that a large part of the ﬂuorescent peptide inserts into the
presynaptic membrane. This is in agreement with the fact that
similar cationic peptides of the C2 domains of Syt bind to the PM
via interaction with anionic phospholipids [16,17,38–40].2.3. The h-JMS peptide binds to anionic phospholipids independently of
Ca2+
Therefore, we assayed the binding of the ﬂuorescent peptide
h-FJMS to a variety of anionic phospholipids. Fig. 7 shows that
the h-FJMS indeed binds anionic phospholipids, including phos-
phatidylserine and phosphatidylinositides (PIs), which are
enriched in the SV membrane and on the cytosolic face of the
PM [39,41]. However, in contrast to the Ca2+-dependent binding
of PIP2 to the C2 domains, the lower panel of Fig. 7 documents
that the h-FJMS peptide binds mono-phosphorylated phospho-
inositides independently of the presence of Ca2+. In addition,
we found little or no binding to the other classes of phospho-
lipids tested, with exception of cardiolipin, which, however, con-
tains two phosphate groups in its molecule. This lipid binding
pattern is similar to the one found previously using the sumoy-
lated Syt 1 peptide 80–96 [42]. Similar anionic lipid binding by a
polybasic juxtamembrane segment were found in syntaxin [43]
and in VAMP [44]. Therefore, it is very unlikely that the present
ﬁnding is an artefact resulting from the presence of the hexyl
and the ﬂuorescent moieties. As PS and PIs are present in the
cytoplasmic side of the presynaptic membrane and on the SV
membrane, this binding may have a great signiﬁcance in the
SV–PM interaction. The possible importance of the cluster of
basic residues in the juxtamembrane segment of the two
SNARE proteins VAMP and syntaxin in the interaction with anio-
nic phospholipids was proposed right after the report of the
structure of the SNARE complex [45] as well as the electrostatic
interaction among proteins and plasma membrane phosphoinosi-
tides [46]. This will be discussed below for the case of the vesi-
cle protein synaptotagmin reported here together with a possible
novel role of the juxtamembrane segment of this protein in
synaptic vesicle membrane fusion.
Fig. 3. Effect of synaptotagmin h-JMS on the neuroexocytosis of primary spinal cord motor neurons. Rat primary motor neurons (7–12 DIV) were loaded with 7 lM FM 1–43
by electrical ﬁeld stimulation. After washing, neurons were exposed to different concentrations of peptide or vehicle; another electric stimulation induces the unloading
phase, which was monitored by ﬂuorescence microscopy, as described in the scheme at the top of panel A). Images were analyzed selecting ﬂuorescent ROI (15–20 for each
experiments) along neurites (with ﬁxed dimensions of 1.6 lm  1.6 lm remaining immobile during experimental time). The ﬂuorescence intensity was plotted for each
region and the slope corresponding to the unloading phase was calculated. A representative trace, corresponding to one ROI is shown as example. B) The graph represents the
average slope of data obtained from four different cell preparations; 2 lM peptide n = 84; 2 lM scrambled peptide n = 42; control n = 84.
Fig. 4. Localization of the ﬂuorescent peptide h-FJMS at the mouse hemidiaphragm neuromuscular junction. The mouse hemidiaphragm neuromuscular junction preparation
was ﬁxed when paralysis caused by 200 lM h-FJMS peptide was attained and immunostained. (A) Fluorescent peptide (green); (B) a-Btx (purple, post synaptic marker); (C)
Basson (red, pre-synaptic active zone marker); (D and E) merged images of the red zone in A. (F) merge of the three markers used, indicating a membrane presynaptic
localization of the ﬂuorescent peptide. Scale bar: 10 lm in A–E; 5 lm in F.
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Fig. 5. Localization of the h-FJMS peptide at the neuromuscular junction. Hemidiaphragm ﬁxed at paralysis and immunostained after treatment with 200 lM FITC-labeled
hexyl-juxtamembrane peptide (h-FJMS). (A) ﬂuorescent peptide (green); (B) a-BTX (purple, post synaptic marker); (C) frontal and (D) lateral merged images, showing the
presynaptic localization of h-FJMS (green).
Fig. 6. Localization of the h-FJMS peptide and synaptic vesicles at the NMJ. Hemidiaphragm ﬁxed at paralysis and immunostained after treatment with 200 lM h-FJMS
peptide. (A) h-FJMS peptide (green); (B) anti VAChT (red); (C) a-BTX (purple, post synaptic marker); (D and E) merged images.
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The main ﬁnding of the present work is that peptides corre-
sponding to the segment 80–98 of Syt 1 (JMS) which is responsible
for Ca2+ triggered neuroexocytosis, cross the plasma membrane
and strongly inhibit neuroexocytosis, most likely by competing
with synaptotagmins at the mouse and D. melanogaster neuromus-
cular junction. The capability of highly cationic peptides to cross
the plasma membrane and enter cells is well documented though
the mechanism(s) and subcellular site(s) of entry are ill deﬁned
[32–34]. The powerful inhibition of neuroexocytosis by JMS pep-
tides, in all likelihood, results from its ability to compete for a
yet undisclosed essential interaction that Syt displays in vivo with
an unknown partner via its juxtamembrane segment. That this
interaction has to occur close to the cytosolic surface of the SV
membrane or the PM membrane, or both, is suggested not only
by the location of JMS with respect to the TM domain of Syt, but
also by the much higher inhibitory activity of the JMS hexyl deriva-
tive that partition in the membrane via its hydrocarbon chain.Accordingly, we have tested the interaction of JMS with phospho-
lipids and have found a deﬁned interaction of JMS with anionic
phospholipids, including PS and phosphorylated derivatives of
phosphatidylinositols, which are present on the cytosolic monolay-
ers of both SV and PM membranes. Such lipid interaction occurs
independently of Ca2+ in the medium, suggesting that the JMS seg-
ment of Syt may interact in vivo both with the SV membrane (cis
interaction) and with the PM (trans interaction). On the basis of
this ﬁnding, we would like to propose that the JMS segment is
deﬁned as a domain of Syt endowed with the function of
Ca2+-independent anionic phospholipid binding. To localize the
site of action of the hexyl derivative JMS peptides, we have used
a ﬂuorescein derivative of the hexyl-JMS domain (h-FJMS of
Fig. 1). Unexpectedly, h-FJMS was found to localize more on the
presynaptic membrane than on the SV present inside the nerve
terminal. The presynaptic labeling of h-FJMS is remarkable and
indicates that its partitioning within the neuromuscular junction
is rather speciﬁc, providing a further indication of the validity of
the results of inhibition of neuroexocytosis. There is little staining
Fig. 7. Lipid binding of the ﬂuorescent h-JMS peptide. PIP-strip membranes spotted by manufacturer with the different phospholipids were incubated with 5 lg/ml peptide
for 75 m, washed and the ﬂuorescence was measured. (A) general lipid binding: TG, triglycerol; DAG: diacylglycerol; PA: phosphatidic acid; PS: phosphatidylserine; PC:
phosphatidylcholine; PG: phosphatidylglycerol; CL: cardiolipin; PI: phosphatidylinositol; PI4P: phosphatidylinositol-4-phosphate; PI(4,5)P: phosphatidylinositol
4,5-bisphosphate, PI(3,4,5): phosphatidylinositol 3,4,5-trisphosphate; COL: cholesterol; SFM: sphingomyelin; SULF: sulfatide. (B) Phosphoinositides binding: LPA:
lysophosphatidic acid; LPC: lysophosphatidylserine; PI: phosphatidylinositol; PI3P: phosphatidylinositol 3-phosphate, PI4P: phosphatidylinositol 4-phosphate; PI5P:
phosphatidylinositol 5-phosphate; PE: phosphatidylethanolamine; PC: phosphatidylcholine; PI(3,4)P: phosphatidylinositol 3,4-bisphosphate; PI(3,5)P: phosphatidylinositol
3,5-bisphosphate; PI(4,5)P: phosphatidylinositol 4,5-bisphosphate; PI(3,4,5)P: phosphatidylinositol 3,4,5-trisphosphate; PA: phosphatidic acid; PS: phosphatidylserine. In
both panels, bars represent the ﬂuorescence for each lipid spot normalized to the blank. A scheme of the PIP-strip membrane used is shown on the right, and the
corresponding number is reported below the graphs. Data are the mean of three independent experiments ± s.d. The images are a representative strip for each experiment.
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present case, an indirect effect of the JMS peptide via
actin-remodeling similar to the one found by Johnsson and
Karlsson [42] in cultured neurons. In fact, neurons in culture bear
little resemblance to the ex vivo NMJ preparations used here, which
include muscle and peripheral Schwann cells.
Clearly, the localization of h-FJMS does not reﬂect that of the JMS
domain as part of the entire Syt molecule in vivo as Syt is an integral
membrane protein of SV and the JMS peptide is a small molecule.
However, this result may be taken as an indication that JMS has a
stronger afﬁnity for the phospholipids of the PM with respect to
those of the SV, though the molecular basis of this preference are
not known. It is possible that the cytosolic face of the plasma mem-
brane contains clusters of phosphoinositides and that this feature
favors a strong interaction with cluster of positive residues of pro-
teins as discussed in [46] and references cited there in. Translated
to the in vivo situation, the localization of h-FJMS may indicate that
JMSmediates cis-interactionswith its ownmembrane, but,whenSV
become close enough to the PM, such as in the case of the docked
vesicles [47], then JMS can switch to a trans-interaction with the
cytosolic face of the PM where PIs are localized, as schematized inFig. 8. Such a possibility posited here for the ﬁrst time is intriguing
and adds to the well deﬁned cis and trans interactions of the C2
domains of Syt in a Ca2+-dependent mode [2,16,17,38,40,48]. The
interaction of the Syt of docked vesicles with anionic phospholipids
of the cytosolic monolayer of the PM would implicate a very close
apposition of the two membranes, thus promoting the possibility
of hemifusion of the vesicle membrane with the plasmamembrane
(Fig. 6). There is an almost general consensus that membrane hemi-
fusion is an essential step preliminary to fast exocytosis [2,31,49,50]
and the possibility that the juxtamembrane domain of synaptotag-
min is involved in membrane hemifusion deserves all the attention
and it is amenable of testing by electronmicroscopy and biophysical
methods.4. Materials and methods
4.1. Antibodies
Rabbit polyclonal anti vesicular acetylcholine transporter
(VAChT) and mouse monoclonal anti Basson are from Synaptic
Fig. 8. A possible role of the synaptotagmin juxtamembrane segment in synaptic vesicle–plasma membrane interaction and hemifusion. (A) synaptic vesicle (SV) near the
presynaptic membrane (PM) before fusion; green segments represent the three polybasic sequences in synaptotagmin, localized in the juxtamembrane segment and in the
two C2 domains capable of anionic phospholipid binding; (B) interaction of the juxtamembrane segment of synaptotagmin residing on a hemifused SV with anionic lipids of
the cytosolic surface of the PM (preferentially mono-phosphorylated phosphoinositides, orange) could favor the close apposition of the two membranes with hemifusion. AZ:
active zone. (C) The rise of calcium (light blue dots) consequent to the opening of calcium channels nearby (not shown) will then cause the C2 domains conformational change
allowing their interaction with PIP2 (red) and the complete membrane fusion. (D) Sequence of the three polybasic peptide segment in mouse and human synaptotagmin 1.
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conjugate and secondary anti mouse-rabbit Alexa Fluor 647 con-
jugate antibodies are from Molecular Probes, Invitrogen (Carlsbad,
CA).
4.2. Peptides synthesis
The synthetic peptide encompassing the synaptotagmin
sequence (80–98) and its derivatives were prepared by solid phase
peptide synthesis using a multiple peptide synthesizer (SyroII,
MultiSynTech GmbH) on Rink Amide MBHA resin (Novabiochem,
Bad Soden, Germany). The ﬂuoren-9-ylmethoxycarbonyl (Fmoc)
strategy [51] was used throughout the peptide chain assembly,
using O-(7-Azabenzotriazol-1-yl)-N,N,N0,N0-tetramethyluronium
hexaﬂuorophosphate (HATU) (ChemPep, Wellington, Fl USA) as
coupling reagent [52]. The side-chain protected amino acid build-
ing blocks used were: N-a-Fmoc-c-tert-butyl-L-glutamic acid, N-
a-Fmoc-Ne-(tert-butyloxycarbonyl)-L-lysine, N-a-Fmoc-Ne-(4-me
thyltrityl)-L-lysine, N-a-Fmoc-S-trityl-cysteine, N-e-(tert-butyloxy
carbonyl)-aminohexanoic acid. Fluorescent labeling was per-
formed during the synthesis with 5(6)-carboxyﬂuorescein (FAM).
For this purpose the peptide (see peptide c, Fig. 1) was synthesized
with an additional N(epsilon) protected lysine with the orthogonal
methyltrityl (Mtt) group. The Mtt group was selectively removed
by treatment with a 10% acetic acid in dichloromethane followed
by a second treatment with 1% triﬂuoroacetic acid, 10% triﬂuo-
roethanol in dichloromethane. Then, the ﬂuorescent probe (FAM)
was pre-activated with DIC (N,N0-diisopropylcarbodiimide) and
HOAt (1-Hydroxy-7-azabenzotriazole) (ChemPep, Wellington, Fl
USA) for 10 min and added to the peptidyl resin. The reaction
proceeded for 2 h under stirring. Cleavage of the peptides was
performed by incubating the peptidyl resins with triﬂuoroacetic
acid/H2O/thioanisole/ethanedithiol/phenol (10 ml/0.5 ml/0.5 ml/
0.25 ml/750 mg) for 2.5 h. Crude peptides were puriﬁed by a
preparative reverse phase HPLC. Molecular masses of the peptidewere conﬁrmed by mass spectroscopy on a MALDI TOF-TOF using
a Applied Biosystems 4800 mass spectrometer.
4.3. Cell cultures
Primary rat spinal cord motor neuron (MNs) were isolated from
Sprague-Dawley rat embryos (embryonic day 14) and cultured fol-
lowing previously described protocols [53]. All experiments were
performed using MNs differentiated for 6–12 days.
4.4. Mouse phrenic nerve-hemidiaphragm preparations
All experimental procedures were performed in accordance
with the Italian guidelines, law n. 116/1992 and were approved
by the Animal Ethical Committee of our University.
Mouse phrenic nerve hemidiaphragms were isolated from male
CD-1 mice weighing about 20–25 g and mounted in 2–3 ml
oxygenated (95% O2, 5% CO2) Krebs–Ringer solution (139 mM
NaCl, 12 mM NaHCO3, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
1 mM KH2PO4 and 11 mM glucose, pH 7.4). Two innervated
hemidiaphragm preparations were isolated from each animal.
4.5. Muscle twitch measurements
The phrenic nerve was stimulated via two ring platinum elec-
trodes with supramaximal stimuli of 10 V amplitude and 0.1 mil-
lisecond pulse duration, with a frequency of 0.1 Hz (Stimulator
6002, Harvard Apparatus, Massachusetts, USA). Muscle contraction
was monitored with an isometric transducer (Harvard Apparatus);
data were recorded and analyzed by the i-WORX 118 system
(Harvard Apparatus). The amplitude of twitch was calculated as a
difference from basal muscular tension and the mean of peak value
measured after stimulation.
Muscles were stretched to the optimal length for twitch tension
and the muscle twitch allowed to stabilize for at least 20 min at
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under this type of stimulation was constant for at least 8 h. The
mean twitch value measured during the last 5–10 min before the
experiment was taken as 100% in order to normalize the data.
Peptides at the indicated concentrations were added to the
nerve-muscle preparations in the minimal volume of buffer.
4.6. Muscle electrophysiology
Experiments in mouse NMJ were performed on mouse phrenic
nerve hemidiaphragm preparations, pinned on silicone-coated
surface (Dow Corning, Germany), maintained in oxygenated
Krebs–Ringer solution, as described previously [54]. A 3 lM ﬁnal
concentration of l-Conotoxin GIIIB (Alomone Labs, Israel) was
added to the bath to block muscle action potentials. Peptides at
the indicated concentrations were added to the nerve-muscle
preparations in the minimal volume of buffer. Evoked Junction
Potentials (EJPs) were intracellularly recorded, in current-clamp
mode, in single muscle ﬁbers using glass microelectrodes following
stimulation of phrenic nerve stump, at 0.5 Hz. Phrenic nerve stump
was stimulated using a suction microelectrode connected to a
stimulator (Grass S88, USA) through a Stimulus Isolation Unit
(SIU5, Grass, USA). Recorded signals were ofﬂine analyzed with
an appropriate software (Pclamp, Molecular Devices, USA).
Relative EJPs amplitude was calculated with respect to the average
of the ﬁrst 10 evoked EJPs recorded in physiological conditions.
4.7. D. melanogaster Electrophysiology
Experiments using the Drosophila NMJ were performed at room
temperature on third instar larval body wall preparations dissected
in Ca2+-free HL3 saline and pinned on the silicone-coated surface
(Dow Corning, Germany) as described previously [10]. After dissec-
tion Ca2+ free HL3 saline was replaced with 1 mM Ca2+ HL3.
Peptides at the indicated concentrations were added to the
nerve-muscle preparations in the minimal volume of buffer.
Electrophysiological recordings were performed on ﬁbers 6 or 7
of abdominal segment 3 or 4 using intracellular glass microelec-
trodes (WPI, Germany). Fibers with a membrane resting potential
lower than 60 mV were rejected. Recorded signals were ofﬂine
analyzed with an appropriate software (Pclamp, Molecular
Devices, USA). Relative EJPs amplitude was calculated with respect
to the average of the ﬁrst 10 EJPs recorded in physiological
conditions.
4.8. FM 1–43 unloading
Rat primary spinal cord motor neurons (7–12 DIV) were loaded
with 7 lM FM 1–43 (Molecular Probes, Invitrogen, Carlsbad, CA) by
electrical ﬁeld stimulation (20 s at 20 Hz, 400 Action Potential, AP).
For each culture, a preliminary test with the calcium binding dye
Fluo 4 (Molecular Probes, Invitrogen, Carlsbad, CA) was performed,
to verify that the voltage applied (15–18 V) induces a transient
Ca2+ inﬂux without damaging cells. After FM 1–43 wash, neurons
were exposed to different concentrations of peptide or vehicle;
the unloading phase was induced with another electric stimulation
(400 AP) and monitored by ﬂuorescence microscopy. Images were
acquired by a Nikon TE2000E stage, and analyzed with the ImageJ
(http://rsbweb.nih.gov/ij/). For each experiment, 15–20 ROIs were
selected with ﬁxed area and dimensions (1.6 lm  1.6 lm) and
remaining immobile during experimental time. The normalized
ﬂuorescence intensity for each region was corrected subtracting
the residual ﬂuorescence at the end of the experiment; for the data
of the initial phase of unloading (ﬁrst 20 s) a linear ﬁtting was per-
formed and the corresponding slope calculated. ROIs with ﬁtting Rsquare below 0.8 were discarded. The average slope was taken as
indicator of the exocytosis speed.
4.9. Protein lipid overlay
‘‘PIP Strips’’ (nitrocellulose membranes prespotted with deﬁned
lipids) were purchased from Echelon Biosciences (Salt Lake City,
UT) and binding overlay experiments were carried out according
to the manufacturer’s protocol. Brieﬂy, the nitrocellulose was
saturated with TrisCl 50 mM, NaCl 150 mM pH 6.8–7, Tween 20
0.5% (TBS-T), BSA FA free 3% over night at 4 C, and then incubated
with 5 lg/ml h-FJMS in the same solution for 2 h at RT. The
nitrocellulose was washed extensively with TBS-T, and the bound
protein was detected by ﬂuorescence assay. Images were taken
using a Kodak Image Station 4000 MM Pro. Integrated densities
at each lipid spot (three replicates) were measured with Image J
and normalized to the blank value for each treatment.
4.10. Fluorescent labeling and Immunohistochemistry
Hemidiaphragms from twitch experiments with the ﬂuorescent
peptide (h-FJMS) were washed and ﬁxed (2 h at room temperature)
with 4% paraformaldehyde, 20% sucrose, washed with PBS and
50 mM NH4Cl for 10 min. Muscles were treated with 2% bovine
serum albumin, 0.25% porcine skin gelatin, 0.2% glycine, and 15%
goat serum in PBS (blocking solution) plus 0.5% Triton X-100 to
permeabilize. Muscles were then incubated with primary antibod-
ies in blocking solution for 24 h at 4 C; after washing, secondary
ﬂuorescent antibody and a-bungarotoxin Alexa-555 were added
and incubated for 2 h at room temperature. Images were collected
from whole-mount preparations in Mowiol (Sigma, St. Louis, MO)
with Leica SP-5 confocal microscope.
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